UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Antibiotics (Basel), 2022-02, Vol.11 (2), p.220

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations

Journal of microbiology, immunology and infection, 2021-12, Vol.54 (6), p.1111-1117

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive models for short-term mortality and length of hospital stay among adults with community-onset bacteraemia before and during the COVID-19 pandemic: application of early data dynamics

BMC infectious diseases, 2023-09, Vol.23 (1), p.1-605, Article 605

2023

Link zum Volltext

Verfügbarkeit prüfen

Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model

Frontiers in microbiology, 2018-01, Vol.8, p.2635

2018

Link zum Volltext

Verfügbarkeit prüfen

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics

Microorganisms (Basel), 2021-07, Vol.9 (8), p.1605

2021

Link zum Volltext

Verfügbarkeit prüfen

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan

PloS one, 2016-11, Vol.11 (11), p.e0166159

2016

Link zum Volltext

Verfügbarkeit prüfen

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases

Pharmaceutics, 2021-11, Vol.13 (11), p.1913

2021

Link zum Volltext

Verfügbarkeit prüfen

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox

Journal of microbiology, immunology and infection, 2022-10, Vol.55 (5), p.795-802

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration

Journal of microbiology, immunology and infection, 2021-04, Vol.54 (2), p.276-283

2021

Link zum Volltext

Verfügbarkeit prüfen

Phage transcriptional regulator X (PtrX)-mediated augmentation of toxin production and virulence in Clostridioides difficile strain R20291

Microbiological research, 2024-03, Vol.280, p.127576-127576, Article 127576

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan

PloS one, 2012-08, Vol.7 (8), p.e42415

2012

Link zum Volltext

Verfügbarkeit prüfen

COVID-19-associated candidiasis and the emerging concern of Candida auris infections

Journal of microbiology, immunology and infection, 2023-08, Vol.56 (4), p.672-679

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan

Emerging microbes & infections, 2020-01, Vol.9 (1), p.2157-2168

2020

Link zum Volltext

Verfügbarkeit prüfen

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity

PloS one, 2016-08, Vol.11 (8), p.e0160760-e0160760

2016

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

Journal of biomedical science, 2024-04, Vol.31 (1), p.1-17

2024

Link zum Volltext

Verfügbarkeit prüfen

Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation

Journal of microbiology, immunology and infection, 2019-12, Vol.52 (6), p.841-850

2019

Link zum Volltext

Verfügbarkeit prüfen

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus

Bioscience of Microbiota, Food and Health, 2022, Vol.41(2), pp.37-44

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure

PloS one, 2013-07, Vol.8 (7), p.e69577

2013

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection

Frontiers in microbiology, 2022-11, Vol.13, p.986457-986457

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of cytokine changes in clozapine‐induced fever: A cohort prospective study

Psychiatry and clinical neurosciences, 2017-06, Vol.71 (6), p.395-402

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan

Journal of microbiology, immunology and infection, 2021-12, Vol.54 (6), p.1122-1129

2021

Link zum Volltext

Verfügbarkeit prüfen

Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan

Journal of microbiology, immunology and infection, 2021-12, Vol.54 (6), p.1101-1110

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients

Frontiers in immunology, 2021-07, Vol.12, p.691039-691039

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents

Pathogens (Basel), 2021-05, Vol.10 (6), p.649

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(112)
Humans
(72)
Microbiology
(66)
Infectious Diseases
(44)
Male
(39)
Animals
(31)
Female
(30)
Immunology
(28)
Middle Aged
(24)
Aged
(21)
Research Article
(21)
Taiwan
(21)
Clostridioides Difficile
(20)
Pharmacology & Pharmacy
(19)
Clostridium Difficile
(18)
Infectious Disease
(18)
Adult
(17)
Anti-Bacterial Agents - Therapeutic Use
(17)
Mice
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations

Predictive models for short-term mortality and length of hospital stay among adults with community-onset bacteraemia before and during the COVID-19 pandemic: application of early data dynamics

Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics

Predominance of Clostridium difficile Ribotypes 017 and 078 among Toxigenic Clinical Isolates in Southern Taiwan

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox

Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration

Phage transcriptional regulator X (PtrX)-mediated augmentation of toxin production and virulence in Clostridioides difficile strain R20291

Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan

COVID-19-associated candidiasis and the emerging concern of Candida auris infections

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus

Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection

Role of cytokine changes in clozapine‐induced fever: A cohort prospective study

Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan

Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan

The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients

Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents

Suchergebnisse filtern